SCHEMBL21035616

SCHEMBL21035616

CC(C)OC(=O)[C@@H]1CC(Nc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.40
ITGB1 P05556 1/20 0.38
ITGA4 P13612 1/20 0.38
HCRTR1 O43613 5/20 0.37
HCRTR2 O43614 5/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MMP2 P08253 4/20 0.37
CCR4 P51679 1/20 0.36
HTR1A P08908 2/20 0.36
HTR7 P34969 2/20 0.36
HTR5A P47898 2/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
HTR6 P50406 1/20 0.36
HTR4 Q13639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035618 0.88 CA12 (0.41) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035612 0.82 GHSR (0.38) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035615 0.82 GHSR (0.38) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035614 0.82 GHSR (0.38) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035398 0.81 HTR1A (0.42) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035317 0.81 HTR1A (0.42) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21034999 0.76 ITGB1 (0.47) ITGB1ITGA4HCRTR1HCRTR2HTR1A
SCHEMBL21034994 0.76 ITGB1 (0.47) ITGB1ITGA4HCRTR1HCRTR2HTR1A
SCHEMBL21035399 0.76 HTR1A (0.44) CNR2ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL21035314 0.76 HTR1A (0.44) CNR2ITGB1ITGA4HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed